Crossmark

What determines the timing of discussions on forgoing anticancer treatment? A national survey of medical oncologists

Published Online: 2018-08-25

Published Print: 2019-04

Authors

Mori, Masanori

Shimizu, Chikako

Ogawa, Asao

Okusaka, Takuji

Yoshida, Saran

Morita, Tatsuya
Funding

Funding for this research was provided by:

National Cancer Center Research and Development Fund (25-B-5)

Mitsubishi Foundation

Japan Hospice Palliative Care Foundation

Japan Society for the Promotion of Science KAKENHI (JP16K15418)
License Information

Text and Data Mining valid from 2018-08-25

Version of Record valid from 2018-08-25
More Information

Article History

Received: 9 May 2018

Accepted: 13 August 2018

First Online: 25 August 2018

Compliance with ethical standards

:

: The funding bodies were not involved in the conducting of this study or its submission. We have no financial or personal relationships with individuals, organizations, or companies that might be perceived as a bias to this work.

: The authors declare that they have no conflict of interest.

Document is current